phase readout
saveNCT07227597: A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
RECRUITINGupdated 3m ago
community read0 votes
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Small Cell Lung Cancer Extensive Stage
view source ↗
comments(0)
5-min edit window · permanent after that